MedC Biopharma Partners with A2W Pharma to develop Cannabinoid Therapeutics
MedC’s proprietary novel cannabinoid formulations for the treatment of various cancer-related indications. A2W is a subsidiary of Amino Chemicals of Malta, which is a subsidiary of ABA Chemicals of China, a global pharmaceutical company. MedC Biopharm is focused on cannabinoid…